Oppenheimer Initiates Coverage On Achieve Life Sciences with Outperform Rating, Announces Price Target of $23
Today, 10:06 PM
Oppenheimer analyst Francois Brisebois initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Outperform rating and announces Price Target of $23.
Barrington Research Initiates Coverage On Cambium Networks with Outperform Rating, Announces Price Target of $75
Today, 10:06 PM
Barrington Research analyst Christopher Howe initiates coverage on Cambium Networks (NASDAQ:CMBM) with a Outperform rating and announces Price Target of $75.
Roth Capital Initiates Coverage On Climate Change Crisis with Buy Rating, Announces Price Target of $21
Today, 10:06 PM
Roth Capital analyst Craig Irwin initiates coverage on Climate Change Crisis (NYSE:CLII) with a Buy rating and announces Price Target of $21.
Berenberg Initiates Coverage On Monday.Com with Buy Rating, Announces Price Target of $280
Today, 10:06 PM
Berenberg analyst Andrew DeGasperi initiates coverage on Monday.Com (NASDAQ:MNDY) with a Buy rating and announces Price Target of $280.
Cantor Fitzgerald Initiates Coverage On Evelo Biosciences with Overweight Rating, Announces Price Target of $28
Today, 10:06 PM
Cantor Fitzgerald analyst Kristen Kluska initiates coverage on Evelo Biosciences (NASDAQ:EVLO) with a Overweight rating and announces Price Target of $28.
Deutsche Bank Initiates Coverage On TechTarget with Buy Rating, Announces Price Target of $80
Today, 10:06 PM
Deutsche Bank analyst Patrick Colville initiates coverage on TechTarget (NASDAQ:TTGT) with a Buy rating and announces Price Target of $80.
Craig-Hallum Initiates Coverage On A10 Networks with Buy Rating, Announces Price Target of $16
Today, 10:06 PM
Craig-Hallum analyst Christian Schwab initiates coverage on A10 Networks (NYSE:ATEN) with a Buy rating and announces Price Target of $16.
Morgan Stanley Initiates Coverage On Centessa Pharmaceuticals with Overweight Rating, Announces Price Target of $37
Today, 10:06 PM
Morgan Stanley analyst Matthew Harrison initiates coverage on Centessa Pharmaceuticals (NASDAQ:CNTA) with a Overweight rating and announces Price Target of $37.
B. Riley Securities Initiates Coverage On Safehold with Buy Rating, Announces Price Target of $100
Today, 10:06 PM
B. Riley Securities analyst Matthew Howlett initiates coverage on Safehold (NYSE:SAFE) with a Buy rating and announces Price Target of $100.